首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   10377篇
  免费   1131篇
  国内免费   695篇
耳鼻咽喉   113篇
儿科学   270篇
妇产科学   17篇
基础医学   392篇
口腔科学   9篇
临床医学   1028篇
内科学   2072篇
皮肤病学   8篇
神经病学   15篇
特种医学   461篇
外科学   1764篇
综合类   1640篇
预防医学   506篇
药学   760篇
  6篇
中国医学   91篇
肿瘤学   3051篇
  2024年   18篇
  2023年   121篇
  2022年   326篇
  2021年   397篇
  2020年   317篇
  2019年   273篇
  2018年   292篇
  2017年   278篇
  2016年   341篇
  2015年   453篇
  2014年   823篇
  2013年   676篇
  2012年   777篇
  2011年   846篇
  2010年   695篇
  2009年   651篇
  2008年   605篇
  2007年   599篇
  2006年   574篇
  2005年   497篇
  2004年   359篇
  2003年   316篇
  2002年   255篇
  2001年   253篇
  2000年   233篇
  1999年   209篇
  1998年   192篇
  1997年   130篇
  1996年   105篇
  1995年   115篇
  1994年   67篇
  1993年   48篇
  1992年   50篇
  1991年   42篇
  1990年   43篇
  1989年   32篇
  1988年   33篇
  1987年   30篇
  1986年   17篇
  1985年   18篇
  1984年   18篇
  1983年   6篇
  1982年   12篇
  1981年   15篇
  1980年   10篇
  1979年   8篇
  1978年   15篇
  1977年   6篇
  1976年   3篇
  1971年   2篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
IntroductionEndoscopic surveillance guidelines for patients with repaired esophageal atresia (EA) rely primarily on expert opinion. Prior to embarking on a prospective EA surveillance registry, we sought to understand EA surveillance practices within the Eastern Pediatric Surgery Network (EPSN).MethodsAn anonymous, 23-question Qualtrics survey was emailed to 181 physicians (surgeons and gastroenterologists) at 19 member institutions. Likert scale questions gauged agreement with international EA surveillance guideline-derived statements. Multiple-choice questions assessed individual and institutional practices.ResultsThe response rate was 77%. Most respondents (80%) strongly agree or agree that EA surveillance endoscopy should follow a set schedule, while only 36% claimed to perform routine upper GI endoscopy regardless of symptoms. Many institutions (77%) have an aerodigestive clinic, even if some lack a multi-disciplinary EA team. Most physicians (72%) expressed strong interest in helping develop evidence-based guidelines.ConclusionsOur survey reveals physician agreement with current guidelines but weak adherence. Surveillance methods vary greatly, underscoring the lack of evidence-based data to guide EA care. Aerodigestive clinics may help implement surveillance schedules. Respondents support evidence-based protocols, which bodes well for care standardization. Results will inform the first multi-institutional EA databases in the United States (US), which will be essential for evidence-based care.Level of EvidenceThis is a prognosis study with level 4 evidence.  相似文献   
2.
目的通过观察二甲双胍对糖尿病合并食管癌患者放疗效果,为糖尿病合并食管癌患者的治疗提供依据。方法选取2016年-2018年在该院确诊的糖尿病合并食管癌并口服二甲双胍降糖治疗的患者51例为观察组,同期诊断糖尿病合并食管癌并皮下注射胰岛素治疗的患者50例为对照组,所有的患者均实施内镜切除联合局部放疗治疗。治疗结束后随访1个月,根据RECIST标准对治疗效果进行评价两组患者的近期疗效。结果观察组患者近期疗效明显优于对照组(P<0.05)。结论二甲双胍可以提高食管癌患者的放疗效果。  相似文献   
3.
4.
随着对胃食管反流病研究的深入,大脑和食管感觉及胃排空的相互作用越来越受到重视,功能磁共振成像技术,有助于进一步了解胃食管反流病的发病机制。  相似文献   
5.
食管癌放疗中二次模拟定位临床探讨   总被引:1,自引:0,他引:1  
目的:探讨食管癌放疗中间再次定位的必要性和重要性。方法:我院放疗科自1998年10月-2001年3月对356例食管癌患者行单纯放疗或放疗加化疗,356例患者照射全过程都进行二次模拟定位(第一次模拟定位后照射30-40GY/15-20次后进行第2次模拟定位)。比较分析前后二次模拟定位靶中心移位的情况。结果;靶中心移位<0.5cm为157例,移位0.5-1.0cm为130例,移位>1.0cm为69例。全部靶中心移位达55.90%。食管肿瘤长度<5cm靶中心移位27例,5-8cm移位117例,病变长度>8cm移位55例,P<0.05;食管肿瘤发生于颈段,上胸段靶中心移位25例,而中、下段食管移位174例,P<0.01。结论:食管肿瘤外照射达到一定剂量时,靶中心会出现不同程度的移位,肿瘤长度越长靶中心移位会更明显, 肿瘤位置越小,移位亦显著。因此,我们对食管癌患者放疗全过程必需进行2到3次定位,这样才能保证靶中心的精确度,以达到预期治疗目的。  相似文献   
6.
Management of upper gastrointestinal bleeding because of erosion of vessels by esophageal cancer may be challenging. We present herein the angiographic images of a 49-year-old patient who was admitted with massive bleeding from a tumor-eroded inferior thyroid artery. Attempts to control the bleeding by means of flexible endoscopy and insertion of a Sengstaken–Blakemore tube had failed. The diagnosis was impressively demonstrated by multislice computed tomography with intravenous contrast in the arterial phase and multiplanar reconstructions (computed tomography angiography) and by digital subtraction angiography. The bleeding was successfully treated with superselective catheterization and coiling of the eroded vessel.  相似文献   
7.
Laparoscopic Heller myotomy (LHM) has become the standard treatment option for achalasia. The incidence of esophageal perforation reported is about 5%–10%. Robotically assisted Heller myotomy (RAHM) is emerging as a safe alternative to LHM. Data comparing the two approaches are scant. The aim of this study was to compare RAHM with LHM in terms of efficacy and safety for treatment of achalasia. A total of 121 patients underwent surgical treatment of achalasia at three institutions. A retrospective review of prospectively collected perioperative data was performed. Patients were divided into two groups: group A (RAHM), 59 patients, and group B (LHM), 62 patients. All the operations were completed using minimally invasive techniques. There were 63 women and 58 men, with a mean age of 45 ±19 years (14–82 years). Fifty-one percent of patients in group A and 95% of patients in group B reported weight loss. Duration of symptoms was equal for both groups. Dysphagia was the main complaint in both groups (P = NS). There was no difference in preoperative endoscopic treatment in both groups (44% versus 27%, P = NS). Operative time was significantly shorter for LHM in the first half of the experience (141 ± 49 versus 122 ± 44 minutes, P < .05). However, in the last 30 cases there was no difference in operative time between the groups (P = NS). Intraoperative complications (esophageal perforation) were more frequent in group B (16% versus 0%). The incidence of postoperative heartburn did not differ by group. There were no deaths. At 18 and 22 months, 92% and 90% of patients had relief of their dysphagia. This study suggests that RAHM is safer than LHM, because it decreases the incidence of esophageal perforation to 0%, even in patients who had previous treatment. At short-term follow-up, relief of dysphagia was equally achieved in both groups. Presented at the Forty-Sixth Annual Meeting of The Society for Surgery of the Alimentary Tract, Chicago, Illinois, May 14–18, 2005 (oral presentation). This study was supported in part by a grant provided by Intuitive Surgical, Inc. and Ethicon Endo-Surgery, Inc.  相似文献   
8.
同步放化疗治疗中晚期食管癌60例   总被引:1,自引:0,他引:1  
目的 观察对中晚期食管癌患者同步放化疗,疗效及毒副作用.方法 中晚期食管癌120例,随机分放化疗组60例(简称放化组)和单纯放疗组60例(简称单放组).放疗采用常规分割,DT40 Gy后缩小照射野,避开脊髓斜野照射,加量DT20~30 Gy,6~7周完成.放化组放疗1、4周后应用顺铂(DDP)20 mg/d、亚叶酸钙(CF)0.1 g/d,CF静脉滴注1/2量时5-氟尿嘧啶(5-Fu)500 mg/d静脉滴注,连续5 d为1个周期,化疗当天进行放疗.结果 放化组与单放组1、2、3年生存率分别为67%、46%、34%和52%、38%、24%;放射性肺炎分别为14例和12例;外周血细胞下降分别为26例和17例;胃肠道反应分别为25例和9例;死亡分别为38例和48例.两组治疗效果比较差异有统计学意义(P<0.05).结论 放疗同步PLF方案化疗治疗中晚期食管癌生存率高,毒副作用及不良反应低.  相似文献   
9.
1材料和方法1.1研究对象1999年3月至2003年2月的238例食管癌根治手术患者,男157例,女81例。年龄60~84岁,平均(66±3.5)岁。其中年龄≥70岁患者36例,包括男24例,女12例,平均(75±3.4)岁。病变长度2.5~8cm。病变位于食管上段19例,中段141例,下段78例。病理类型:鳞癌206例,腺癌2  相似文献   
10.
目的 设计封堵食管胃吻合口-胸腔瘘的覆膜内支架。方法 根据食管胃吻合口区的特殊解剖结构和吻合口胸腔瘘的病变特点,设计蘑菇状覆膜内支架。透视下,5例吻合口巨大胸腔瘘患者置入6枚蘑菇状覆膜内支架。结果 蘑菇状覆膜内支架能有效封堵食管胃吻合口巨大胸腔瘘,解决了进食问题,改善了营养状况。结论 蘑菇状覆膜内支架结构设计合理,操作简单、安全,近期疗效明显,是一项值得推广的新技术。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号